p53 is a tumor suppressor, and studies regarding pancreatic cancer have shown that BMAL1 promotes p53 transcription by directly binding to the p53 promoter, thereby transcriptionally activating the downstream tumor suppressor pathway in a p53-dependent manner [20]. Here, TP53 is linked to pancreatic neoplasm.